Market snapshot: Mankind Pharma’s wholly-owned subsidiary, Bharat Serums and Vaccines Limited, has received approval from its members for voluntary liquidation. This decision was formalized during an Extraordinary General Meeting on September 7, 2026, as part of a strategic corporate restructuring to integrate operations into the parent company. The liquidation remains contingent on obtaining necessary creditor consent under the Insolvency and Bankruptcy Code, 2016.
Data Snapshot
- Mankind Pharma completed the acquisition of a 100% stake in Bharat Serums and Vaccines Limited for a cash consideration of ₹13,768 crore.
- Mankind Pharma previously acquired the Branded Generic Business relating to the Women’s Health Portfolio of Bharat…